Is MMR a Live Vaccine?
Yes, MMR is a live attenuated vaccine containing weakened strains of measles, mumps, and rubella viruses that replicate in the body to generate protective immunity. 1, 2, 3
Vaccine Composition and Mechanism
MMR contains live attenuated viral strains that are specifically weakened to replicate at body temperature while producing robust immune responses without causing disease in immunocompetent individuals. 4, 5, 3
Active viral replication occurs 6-12 days post-vaccination, with peak replication generating fever in approximately 21.5% of recipients and measles-like rash in 3% during this timeframe. 5, 6
Seroconversion rates reach 95-100% for each vaccine component, demonstrating that the live viruses replicate sufficiently to stimulate long-lasting, potentially lifelong immunity. 5, 3
Critical Contraindications Due to Live Virus Nature
Severely Immunocompromised Patients
MMR is absolutely contraindicated in severely immunocompromised individuals because enhanced viral replication can lead to disseminated vaccine-strain infection and death. 1, 2, 4
Severe immunocompromise is defined as: 4
- Congenital immunodeficiency disorders
- HIV infection with severe immunosuppression (CD4 count criteria apply)
- Active hematologic or generalized malignancy
- Current chemotherapy with alkylating agents, antimetabolites, or radiation
- High-dose corticosteroids (≥2 mg/kg/day or ≥20 mg/day prednisone equivalent for ≥14 days)
Important exception: Asymptomatic HIV-infected persons without severe immunosuppression SHOULD receive MMR, and symptomatic HIV-infected persons may be considered for vaccination. 1, 7, 4
Pregnancy
MMR should not be administered to pregnant women due to theoretical risk of fetal harm from live virus vaccine, though no evidence exists that it causes congenital malformations. 1, 8, 1, 9
- Women should avoid pregnancy for 3 months after MMR or rubella-containing vaccines (30 days for monovalent mumps vaccine). 10, 9
- If inadvertently vaccinated during pregnancy, this should NOT be considered an indication for pregnancy termination, as no documented cases of vaccine-induced fetal damage exist. 1, 10, 1
Timing Considerations Around Immunosuppression
Administer MMR ≥4 weeks before initiating immunosuppressive therapy when possible. 4
Wait ≥3 months after discontinuation of chemotherapy or high-dose corticosteroids before administering MMR. 1, 7, 4
- Patients with leukemia in remission may receive MMR after 3 months off chemotherapy. 1, 7, 4
- Short-term (<2 weeks), low-to-moderate dose corticosteroids, topical steroids, or alternate-day treatment do NOT contraindicate MMR. 1
Protection of Immunocompromised Patients Through Herd Immunity
All household contacts and healthcare workers of immunocompromised persons should receive MMR vaccine to provide indirect protection, as transmission of vaccine strains is extraordinarily rare (except rarely via breast milk). 2, 4, 6
Interaction with Immune Globulin Products
MMR should be given ≥14 days before, or deferred for ≥6 weeks (preferably 3 months) after administration of immune globulin, whole blood, or antibody-containing blood products because passively acquired antibodies can interfere with vaccine virus replication and immune response. 8, 7
Common Pitfalls to Avoid
Do not confuse contact dermatitis to neomycin with anaphylaxis: Contact dermatitis is NOT a contraindication to MMR, but anaphylactic reactions to neomycin are. 1, 6
Egg allergy is NOT a contraindication: Despite mumps component production in chick embryo fibroblasts, anaphylactic reactions are associated with gelatin or other components, not egg antigens. 9, 6
Do not withhold MMR for minor febrile illness: Only severe febrile illness warrants postponement; mild upper respiratory infections should not delay vaccination. 1